{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:00:57Z","timestamp":1790164857978,"version":"4.1.0"},"reference-count":50,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"FCT\u2014Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["UID\/04378\/2025"],"award-info":[{"award-number":["UID\/04378\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT\u2014Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["UID\/PRR\/04378\/2025"],"award-info":[{"award-number":["UID\/PRR\/04378\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT\u2014Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["LA\/P\/0140\/2020"],"award-info":[{"award-number":["LA\/P\/0140\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"award":["UID\/04378\/2025"],"award-info":[{"award-number":["UID\/04378\/2025"]}],"id":[{"id":"https:\/\/ror.org\/00snfqn58","id-type":"ROR","asserted-by":"publisher"}]},{"award":["UID\/PRR\/04378\/2025"],"award-info":[{"award-number":["UID\/PRR\/04378\/2025"]}],"id":[{"id":"https:\/\/ror.org\/00snfqn58","id-type":"ROR","asserted-by":"publisher"}]},{"award":["LA\/P\/0140\/2020"],"award-info":[{"award-number":["LA\/P\/0140\/2020"]}],"id":[{"id":"https:\/\/ror.org\/00snfqn58","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Research Unit on Applied Molecular Biosciences\u2014UCIBIO","award":["LA\/P\/0140\/2020"],"award-info":[{"award-number":["LA\/P\/0140\/2020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Invasive Candidiasis (IC) remains a critical threat to global health. Primarily caused by Candida albicans, it is increasingly driven by emerging Non-Candida albicans Candida Species (NCACs). IC typically arises from the overgrowth of commensal Candida species in immunocompromised hosts. IC accounts for an estimated 250,000\u2013700,000 cases annually worldwide, with mortality rates between 40 and 55%, and contributes to more than 1.5 million annual deaths. Despite progress in healthcare systems, intensive care, and microbiological techniques, mortality rates remain largely unchanged. Triazole resistance is already widespread, and echinocandin resistance, while still low, is steadily climbing. The emergence of multidrug-resistant Candida auris, the growing immunocompromised population, and the absence of any antifungal vaccine collectively define this scenario as a therapeutic impasse. Given these challenges, there is an urgent need to synthesize current vaccine research to identify robust candidates and address lingering translational bottlenecks. This structured narrative review evaluates the advances and barriers in Candida spp. vaccine development over the past decade (2015\u20132025), structured around epidemiology and resistance; immunological framework underpinning vaccine design; antigenic targets and delivery platforms; and preclinical and clinical evidence. Key milestones included the Phase II clinical validation of NDV-3A, the first successful large-scale human trial of a fungal vaccine; the standardization of the A\/J mouse model for C. auris; the emergence of multi-epitope computational platforms with &gt;94% HLA population coverage; and cross-kingdom protection paradigms. Major obstacles included commensal-to-pathogen duality of Candida, immunocompromised host paradox, antigenic plasticity, and chronic underinvestment. Converging next-generation vaccine strategies are beginning to bridge the gap between bench discovery and clinical implementation.<\/jats:p>","DOI":"10.3390\/ijms27198490","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:09:08Z","timestamp":1790161748000},"page":"8490","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Closing the Gap: Advances and Barriers on Candida Vaccines Development in the Last Decade"],"prefix":"10.3390","volume":"27","author":[{"given":"Julie","family":"Krier","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, University Institute of Health Sciences (IUCS-CESPU), 4585-116 Gandra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9086-4862","authenticated-orcid":false,"given":"Jontana","family":"Allkja","sequence":"additional","affiliation":[{"name":"Open Innovation Hub for Antimicrobial Surfaces, Surface Science Research Centre, School of Physical Sciences, University of Liverpool, Liverpool L69 3BX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2245-5316","authenticated-orcid":false,"given":"Alexandra M\u00f3nica Bastos","family":"Viana da Costa","sequence":"additional","affiliation":[{"name":"Associate Laboratory i4HB\u2014Institute for Health and Bioeconomy, University Institute of Health Sciences\u2014CESPU, 4585-116 Gandra, Portugal"},{"name":"UCIBIO\u2014Applied Molecular Biosciences Unit, Translational Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5960-3610","authenticated-orcid":false,"given":"Francisco A. M.","family":"Silva","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University Institute of Health Sciences (IUCS-CESPU), 4585-116 Gandra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8633-2230","authenticated-orcid":false,"given":"C\u00e9lia Fortuna","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University Institute of Health Sciences (IUCS-CESPU), 4585-116 Gandra, Portugal"},{"name":"Associate Laboratory i4HB\u2014Institute for Health and Bioeconomy, University Institute of Health Sciences\u2014CESPU, 4585-116 Gandra, Portugal"},{"name":"UCIBIO\u2014Applied Molecular Biosciences Unit, Translational Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal"},{"name":"LEPABE\/ALiCE\u2014Laboratory for Process Engineering, Environment, Biotechnology and Energy and Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/CLEP.S459600","article-title":"Epidemiology of invasive candidiasis","volume":"16","author":"Bays","year":"2024","journal-title":"Clin. Epidemiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/jac\/dkad139","article-title":"Invasive candidiasis: Current clinical challenges and unmet needs in adult populations","volume":"78","author":"Soriano","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Branda, F., Petrosillo, N., Ceccarelli, G., Giovanetti, M., De Vito, A., Madeddu, G., Scarpa, F., and Ciccozzi, M. (2025). Antifungal agents in the 21st century: Advances, challenges, and future perspectives. Infect. Dis. Rep., 17.","DOI":"10.3390\/idr17040091"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the epidemiological landscape of invasive candidiasis","volume":"73","author":"Lamoth","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Tso, G.H.W., Reales-Calderon, J.A., and Pavelka, N. (2018). The elusive anti-Candida vaccine: Lessons from the past and opportunities for the future. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00897"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Sahu, S.R., Bose, S., Singh, M., Kumari, P., Dutta, A., Utkalaja, B.G., Patel, S.K., and Acharya, N. (2022). Vaccines against candidiasis: Status, challenges and emerging opportunity. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.1002406"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kaur, G., Chawla, S., Kumar, P., and Singh, R.R. (2023). Advancing vaccine strategies against Candida infections: Exploring new frontiers. Vaccines, 11.","DOI":"10.3390\/vaccines11111658"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.biopha.2018.10.075","article-title":"Fungal vaccines, mechanism of actions and immunology: A comprehensive review","volume":"109","author":"Nami","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.biopha.2018.12.009","article-title":"Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases","volume":"110","author":"Nami","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Du, W., Wang, Q., and Zhao, M. (2025). Innovative antifungal strategies to combat drug-resistant Candida auris: Recent advances and clinical implications. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1641373"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/21505594.2015.1004977","article-title":"Adaptive immune responses to Candida albicans infection","volume":"6","author":"Richardson","year":"2015","journal-title":"Virulence"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cyto.2015.07.025","article-title":"Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species","volume":"76","author":"Whibley","year":"2015","journal-title":"Cytokine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1039\/D3SC01242E","article-title":"Synthesis of oligosaccharides to identify an immunologically active epitope against Candida auris infection","volume":"14","author":"Singh","year":"2023","journal-title":"Chem. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e00339-19","DOI":"10.1128\/mSphere.00339-19","article-title":"Experimental mouse models of disseminated Candida auris infection","volume":"4","author":"Xin","year":"2019","journal-title":"mSphere"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mib.2017.10.018","article-title":"Modulating host immune responses to fight invasive fungal infections","volume":"40","author":"Scriven","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"110550","DOI":"10.1016\/j.biopha.2020.110550","article-title":"Immune defence to invasive fungal infections: A comprehensive review","volume":"130","author":"Pathakumari","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.immuni.2015.01.008","article-title":"Candida albicans morphology and dendritic cell subsets determine T helper cell differentiation","volume":"42","author":"Kashem","year":"2015","journal-title":"Immunity"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"127964","DOI":"10.1016\/j.micres.2024.127964","article-title":"Extracellular Hsp90 of Candida albicans contributes to the virulence of the pathogen by activating the NF-\u03baB signaling pathway and inducing macrophage pyroptosis","volume":"290","author":"Fang","year":"2025","journal-title":"Microbiol. Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Shukla, M., Chandley, P., and Rohatgi, S. (2021). The role of B-cells and antibodies against Candida vaccine antigens in invasive candidiasis. Vaccines, 9.","DOI":"10.3390\/vaccines9101159"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijbiomac.2021.01.105","article-title":"Chitosan hydrogel loaded with recombinant protein containing epitope c from HSP90 of Candida albicans induces protective immune responses against systemic candidiasis","volume":"173","author":"Li","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s43141-022-00415-3","article-title":"Design of a multi-epitope vaccine against the pathogenic fungi Candida tropicalis using an in silico approach","volume":"20","author":"Akhtar","year":"2022","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1016\/j.vaccine.2018.08.011","article-title":"Phage vaccines displaying YGKDVKDLFDYAQE epitope induce protection against systemic candidiasis in mouse model","volume":"36","author":"Shi","year":"2018","journal-title":"Vaccine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"105462","DOI":"10.1016\/j.compbiomed.2022.105462","article-title":"Subtractive proteomics assisted therapeutic targets mining and designing ensemble vaccine against Candida auris for immune response induction","volume":"145","author":"Khan","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"100474","DOI":"10.1016\/j.jgeb.2025.100474","article-title":"Designing of multi-valent epitope vaccine displaying interactions with diverse HLA alleles against Candida auris using immunoinformatics","volume":"23","author":"Ahlawat","year":"2025","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/acsinfecdis.5b00104","article-title":"6-O-branched oligo-\u03b2-glucan-based antifungal glycoconjugate vaccines","volume":"2","author":"Liao","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3897\/pharmacia.68.e49384","article-title":"The study of the therapeutic effectiveness of the associated inactivated and subunit vaccines based on Candida albicans and Candida tropicalis fungi","volume":"68","author":"Rybalkin","year":"2021","journal-title":"Pharmacia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"102862","DOI":"10.1016\/j.jddst.2021.102862","article-title":"Synthesis and evaluation of metallic nanoparticles-based vaccines against Candida albicans infections","volume":"68","author":"Abdelnaby","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_28","first-page":"309","article-title":"Vaccines in the treatment of invasive candidiasis","volume":"6","author":"Wang","year":"2015","journal-title":"Virulence"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.actbio.2016.05.001","article-title":"Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis","volume":"39","author":"Carneiro","year":"2016","journal-title":"Acta Biomater."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e00189-24","DOI":"10.1128\/msphere.00189-24","article-title":"Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis","volume":"9","author":"Huang","year":"2024","journal-title":"mSphere"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijbiomac.2015.07.047","article-title":"Vaccine potential of plasma bead-based dual antigen delivery system against experimental murine candidiasis","volume":"81","author":"Ahmad","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Luberto, L., Neroni, B., Gandini, O., Fiscarelli, E.V., Salvatori, G., Roscilli, G., and Marra, E. (2021). Genetic vaccination as a flexible tool to overcome the immunological complexity of invasive fungal infections. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.789774"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e13238","DOI":"10.1111\/cmi.13238","article-title":"Protective effect of fungal extracellular vesicles against murine candidiasis","volume":"22","author":"Vargas","year":"2020","journal-title":"Cell. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"104879","DOI":"10.1016\/j.micpath.2021.104879","article-title":"In silico design of a multivalent epitope-based vaccine against Candida auris","volume":"155","author":"Akhtar","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100489","DOI":"10.1016\/j.jgeb.2025.100489","article-title":"The evaluation of a novel multi-epitope vaccine against human papillomavirus and Candida albicans","volume":"23","author":"Ahmadifar","year":"2025","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Singh, S., Uppuluri, P., Mamouei, Z., Alqarihi, A., Elhassan, H., French, S., Lockhart, S.R., Chiller, T., Edwards, J.E., and Ibra-him, A.S. (2019). The NDV-3A vaccine protects mice from multidrug-resistant Candida auris infection. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007460"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1038\/s41598-019-42517-y","article-title":"NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice","volume":"9","author":"Alqarihi","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/j.vaccine.2021.06.001","article-title":"Synthetic conjugate peptide Fba-Met6 (MP12) induces complement-mediated resistance against disseminated Candida albicans","volume":"39","author":"Adams","year":"2021","journal-title":"Vaccine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"127102","DOI":"10.1016\/j.vaccine.2025.127102","article-title":"A synthetic peptide vaccine induces protective immune responses against Candida albicans infection in immunocompromised mice","volume":"53","author":"Diez","year":"2025","journal-title":"Vaccine"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Bono, C., Guerrero, P., Jord\u00e1n-Pla, A., Erades, A., Salomonis, N., Grimes, H.L., Gil, M.L., and Y\u00e1\u00f1ez, A. (2021). GM-CSF programs hematopoietic stem and progenitor cells during Candida albicans vaccination for protection against reinfection. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.790309"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis\u2014A phase 2 randomized, double-blind, placebo-controlled trial","volume":"66","author":"Edwards","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00253-025-13478-2","article-title":"Candida albicans: The current status regarding vaginal infections","volume":"109","author":"Faustino","year":"2025","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Feng, Z., Lu, H., and Jiang, Y. (2024). Promising immunotherapeutic targets for treating candidiasis. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1339501"},{"key":"ref_44","first-page":"204993612311613","article-title":"Flucytosine and its clinical usage","volume":"10","author":"Sigera","year":"2023","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_45","first-page":"79","article-title":"Management of invasive candidiasis in the ICU: Challenges and advances (review)","volume":"5","author":"Elmasry","year":"2025","journal-title":"Med. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"101752","DOI":"10.1016\/j.smim.2023.101752","article-title":"Exploiting antifungal immunity in the clinical context","volume":"67","author":"Lionakis","year":"2023","journal-title":"Semin. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Segal, E., and Frenkel, M. (2018). Experimental in vivo models of candidiasis. J. Fungi, 4.","DOI":"10.3390\/jof4010021"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00203-024-04010-7","article-title":"Fungal vaccines and adjuvants: A tool to reveal the interaction between host and fungi","volume":"206","author":"Wang","year":"2024","journal-title":"Arch. Microbiol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Youssef, E.G., Zhang, L., Alkhazraji, S., Gebremariam, T., Singh, S., Yount, N.Y., Yeaman, M.R., Uppuluri, P., and Ibrahim, A.S. (2020). Monoclonal IgM antibodies targeting Candida albicans Hyr1 provide cross-kingdom protection against Gram-negative bacteria. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00076"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ivanov, M., \u0106iri\u0107, A., and Stojkovi\u0107, D. (2022). Emerging antifungal targets and strategies. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052756"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8490\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:11:23Z","timestamp":1790161883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":50,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["ijms27198490"],"URL":"https:\/\/doi.org\/10.3390\/ijms27198490","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]}}}